| # | Drug | Count |
|---|---|---|
| 0 | RIBOCICLIB | 55 |
| 1 | LETROZOLE | 25 |
| 2 | LETROZOLE TABLETS | 22 |
| 3 | ACETAMINOPHEN | 21 |
| 4 | ACETAMINOPHEN 500MG | 18 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 18 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 18 |
| 7 | DIPHENHYDRAMINE | 18 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 18 |
| 9 | FULVESTRANT | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PLATINUM | 1 | 0.0019 |
| 1 | RIBOCICLIB | 55 | 0.0017 |
| 2 | PILOCARPINE HYDROCHLORIDE | 4 | 0.0016 |
| 3 | DACOMITINIB | 1 | 0.0013 |
| 4 | FULVESTRANT | 18 | 0.0005 |
| 5 | LETROZOLE TABLETS | 22 | 0.0004 |
| 6 | LETROZOLE | 25 | 0.0004 |
| 7 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 8 | 0.0003 |
| 8 | ZOLEDRONIC ACID | 13 | 0.0003 |
| 9 | IBANDRONATE SODIUM | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 26 |
| 1 | Corticosteroid [EPC] | 22 |
| 2 | Kinase Inhibitor [EPC] | 21 |
| 3 | Estrogen Receptor Antagonist [EPC] | 18 |
| 4 | Expectorant [EPC] | 18 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 16 |
| 8 | Calcium [EPC] | 15 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 18 | 0.0004 |
| 1 | Aromatase Inhibitor [EPC] | 26 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 16 | 0.0001 |
| 5 | Calcium [EPC] | 15 | 0.0001 |
| 6 | Expectorant [EPC] | 18 | 0.0001 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 16 | 0.0001 |
| 8 | Bile Acid [EPC] | 1 | 0.0000 |
| 9 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |